Phasic increases in brain dopamine are required for cuedirected reward seeking. Although compelling within the framework of appetitive behavior, the view that illicit drugs hijack reward circuits by hyperactivating these dopamine transients is inconsistent with established psychostimulant pharmacology. However, recent work reclassifying amphetamine (AMPH), cocaine, and other addictive dopamine-transporter inhibitors (DAT-Is) supports transient hyperactivation as a unifying hypothesis of abused drugs. We argue here that reclassification also identifies generating burst firing by dopamine neurons as a keystone action. Unlike natural rewards, which are processed by sensory systems, drugs act directly on the brain. Consequently, to mimic natural rewards and exploit reward circuits, dopamine transients must be elicited de novo. Of available drug targets, only burst firing achieves this essential outcome. Dopamine, psychostimulants, and reinforcement A long-held tenet in the pharmacology of abused drugs is that, despite marked differences in cellular targets, all classes of these substances increase brain levels of extracellular dopamine [1]. Drug-induced dopamine elevations occur to the greatest extent in the nucleus accumbens (NAc), a brain region that is crucial for translating motivational input into behavioral output [2,3]. This shared outcome of a hyper-dopamine state is thought to mediate the initial reinforcing properties of abused drugs (Box 1), the general focus of this Opinion article. Not unexpectedly, extensive work has been directed at refining this general scheme, and abused drugs have been classified on the basis of specific mechanisms for targeting dopamine neurons [4,5]. Moreover, there is an emergent hypothesis that abused drugs hijack reward circuits by hyperactivating extracellular phasic (1-2 s) signals called dopamine transients [6,7]. Although attractive with regard to the processing of natural rewards by phasic dopamine signaling in appetitive behavior, this hypothesis is inconsistent with currently accepted mechanisms for how addictive DAT-Is, including AMPH, methamphetamine, cocaine, and methylphenidate (Ritalin1), act on dopamine neurons.
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In this Opinion we highlight recent work calling for reclassifying these psychostimulants (see Glossary). We argue that this reclassification reconciles dopamine theories of appetitive behavior and the hijacking of reward circuits by abused drugs with a mechanistic understanding of psychostimulant action on dopamine neurons. We begin by summarizing the role of phasic dopamine signaling in appetitive behavior, the emergent hypothesis that abused drugs usurp this process, and the traditional view of drug action on dopamine neurons. On the basis of reclassifying DAT-Is, and by virtue of eliciting dopamine transients de novo, we then argue that generating burst firing by dopamine neurons is the keystone action by which abused drugs hijack reward circuits.
Opinion
Glossary Dopamine transporter (DAT): DAT is a plasma membrane protein that is a member of the SLC6 (solute carrier 6) gene family of Na + /Cl --dependent transporters and terminates dopamine signaling by clearing extracellular dopamine released by exocytosis [104] . Uptake via DAT also contributes to recycling dopamine because newly re-uptaken dopamine is repackaged into vesicles by the vesicular monoamine transporter for re-release. DAT-Is target DAT and have been traditionally thought to exert their effects on drug reinforcement by inhibiting dopamine uptake. Psychostimulants: a class of drugs that increase psychomotor activity and exhibit antidepressant effects, and act by increasing monoamine (e.g., dopamine, norepinephrine, and serotonin) levels in the brain [105] . Popular psychostimulants, such as cocaine, amphetamine, methamphetamine, and ecstasy, produce feelings of euphoria, relief from fatigue, improved performance on some simple tasks, and anorexia. Drug reinforcement: in general, reinforcement (positive or negative) refers to an increase in behavior directed toward a particular outcome [106] . Similarly to natural rewards, abused drugs promote positive reinforcement. Drug reinforcement is demonstrated by the paradigm of drug self-administration, in which delivery of abused drugs contingent on an instrumental response (e.g., lever pressing or nose poking) increases the likelihood that the response is made. Conditioned stimulus: a conditioned stimulus (e.g., a tone or light) is predictively and temporally associated with an unconditioned stimulus (e.g., natural reward or abused drug). Although initially neutral and evoking no innate response, after associative learning the conditioned stimulus evokes a conditioned response similar to that evoked by the unconditioned stimulus. Drug-conditioned stimuli come to elicit approach behavior and support the maintenance of drug taking. They also can act as conditioned reinforcers driving instrumental responding [20] and are crucial for the reinstatement of drug seeking and taking even after long periods of abstinence [6] . Fast-scan cyclic voltammetry (FSCV): an electrochemical, microsensor-based approach for temporally, spatially, and chemically resolving neurochemicals in situ [10] . The typical microsensor is the carbon-fiber microelectrode (CFM). For dopamine measurements using FSCV in awake animals, the potential of the CFM is linearly scanned from -0.4 to +1.3 V and back at regular 10 Hz intervals. FSCV is so named because the potential sweep is cyclical and made at high rates (e.g., 400 V/s). Dopamine is oxidized to dopamine-o-quinone at +0.65 V during the positive sweep, and this is reduced back to dopamine at -0. 
